We are partnering with an established and growing biotechnology consultancy that supports innovative organisations across the life sciences sector. As they continue to grow, they are looking to appoint a Medicinal Chemistry Consultant on an ad hoc basis to support projects as they come in. This position is fully remote and outside of IR35 for UK candidates.
This role requires an experienced Medicinal Chemistry Consultant specialising in lead optimisation to provide expert scientific and technical support across small-molecule discovery programmes. The role involves senior-level advisory input, direction of compound design and synthesis, and integration of biological, DMPK and safety data to support selection of candidates suitable for preclinical development.
Key Responsibilities:
Provide expert medicinal chemistry advice and strategic input across lead optimisation programmes, defining priorities and progression criteria to balance biological activity, drug-like properties and potential safety risks.
Design improved compounds through targeted structural modifications, proposing and prioritising analogues and directing synthesis by internal chemistry teams or contract research organisations (CROs) to address specific programme objectives.
Develop and interpret structure–activity and structure–property relationships, integrating experimental results to understand how chemical modifications affect potency, selectivity, physicochemical properties and overall compound performance.
Optimise potency and selectivity against the intended biological target, interpreting biochemical and cellular assay results and off-target profiling data in collaboration with biology and pharmacology specialists.
Improve drug-like properties including solubility, permeability and metabolic stability, using measured data and appropriate predictive approaches to guide compound design and resolve barriers to progression.
Work closely with drug metabolism and pharmacokinetics (DMPK) specialists to interpret metabolism, clearance, bioavailability and exposure data, guiding structural changes to achieve suitable pharmacokinetic profiles for the intended use.
Identify and address potential safety liabilities with DMPK and toxicology specialists, including reactive metabolite formation, unwanted target activity and drug–drug interaction potential, incorporating findings into compound design decisions.
Support CRO selection and technical oversight, reviewing synthesis plans, compound identity and purity data, project deliverables and timelines to ensure reliable provision of compounds for biological and DMPK evaluation.
Support candidate selection by integrating chemistry, biological, DMPK and preliminary safety evidence, assessing remaining risks and recommending compounds for progression against agreed candidate profiles and programme criteria.
Prepare and review medicinal chemistry reports, compound progression recommendations and candidate selection rationales, communicating findings clearly to multidisciplinary project teams and supporting handover to preclinical and chemical development colleagues.
Requirements:
Degree or equivalent in medicinal chemistry, organic chemistry or a related discipline.
Demonstrated experience delivering small-molecule lead optimisation programmes, ideally through candidate selection for preclinical development.
Strong working knowledge of compound design, synthetic chemistry, structure–activity relationships and optimisation of drug-like properties.
Proven experience integrating biological, DMPK and safety data and directing internal chemistry teams or CRO activities.
Comfortable operating in senior advisory or consultancy roles, with the ability to communicate complex medicinal chemistry concepts clearly to multidisciplinary teams.